Division of Pediatric Cardiology, Department of Pediatrics, Rady Children's Hospital, University of California, San Diego, CA; Division of Pediatric Cardiology, Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, CA.
University of California San Diego School of Medicine, San Diego, CA.
J Pediatr. 2022 Mar;242:18-24. doi: 10.1016/j.jpeds.2021.11.011. Epub 2021 Nov 11.
To identify the etiologies of viral myocarditis in children in the pre-coronavirus disease 2019 era.
This was a retrospective review of all patients (age <18 years) diagnosed with myocarditis and hospitalized at Rady Children's Hospital San Diego between 2000 and 2018.
Twenty-nine patients met inclusion criteria. Of 28 (97%) patients who underwent testing for viruses, polymerase chain reaction was used in 24 of 28 (86% of cases), and 16 of 24 (67%) detected a virus. Pathogens were rhinovirus (6), influenza A/B (4), respiratory syncytial virus (RSV) (3), coronavirus (3), parvovirus B19 (2), adenovirus (2), and coxsackie B5 virus, enterovirus, and parainfluenza virus type 2 in one case each. Six (21%) patients had no pathogen detected but imaging and other laboratory test results were compatible with myocarditis. Age 0-2 years was associated with RSV, influenza A/B, coronavirus, and enteroviruses (P < .001). Twenty-one patients (72%) experienced full clinical recovery. Three patients (10%) required venoarterial extracorporeal membrane oxygenation (VA-ECMO), and all 3 recovered. Three others (10%) required and underwent successful cardiac transplantation without complications. Two patients (7%) died 9-10 days after hospitalization (1 had RSV and 1 had influenza A/B). Two other patients presented with complete atrioventricular block; 1 case (rhinovirus) resolved spontaneously, and 1 (coronavirus) resolved after support with VA-ECMO. Age <2 years, female sex, lower ejection fraction at admission, and greater initial and peak levels of brain natriuretic peptide were significant predictors of critical outcomes (use of VA-ECMO, listing for cardiac transplantation, and death).
Viral nucleic acid-based testing revealed a wider spectrum of viruses that could be associated with myocarditis in children than previously reported and traditionally anticipated. A predilection of certain pathogens in the very young patients was observed. Whether the observed range of viral agents reflects an undercurrent of change in viral etiology or viral detection methods is unclear, but the wider spectrum of viral pathogens found underscores the usefulness of polymerase chain reaction testing to explore possible viral etiologies of myocarditis in children.
确定 2019 年冠状病毒病前儿童病毒性心肌炎的病因。
这是对 2000 年至 2018 年期间在圣地亚哥 Rady 儿童医院住院的所有(年龄<18 岁)诊断为心肌炎的患者进行的回顾性研究。
29 名患者符合纳入标准。在接受病毒检测的 28 名(97%)患者中,24 名患者(86%的病例)进行了聚合酶链反应检测,其中 16 名患者(67%)检测到病毒。病原体为鼻病毒(6)、甲型/乙型流感(4)、呼吸道合胞病毒(RSV)(3)、冠状病毒(3)、细小病毒 B19(2)、腺病毒(2)和柯萨奇 B5 病毒、肠病毒和副流感病毒 2 型各 1 例。6 名(21%)患者未检测到病原体,但影像学和其他实验室检查结果与心肌炎相符。0-2 岁年龄与 RSV、甲型/乙型流感、冠状病毒和肠病毒相关(P<0.001)。21 名患者(72%)完全临床康复。3 名患者(10%)需要静脉-动脉体外膜肺氧合(VA-ECMO),所有 3 名患者均康复。另外 3 名(10%)患者需要并成功进行了心脏移植,没有并发症。2 名患者(7%)在住院后 9-10 天死亡(1 例为 RSV,1 例为甲型/乙型流感)。另外 2 名患者出现完全性房室传导阻滞;1 例(鼻病毒)自发缓解,1 例(冠状病毒)在接受 VA-ECMO 支持后缓解。年龄<2 岁、女性、入院时射血分数较低以及脑钠肽初始和峰值水平较高是发生严重结局(使用 VA-ECMO、心脏移植和死亡)的显著预测因素。
基于病毒核酸的检测显示,与之前报道和传统预期相比,儿童心肌炎可能与更多种病毒有关。在非常年幼的患者中观察到某些病原体的倾向。观察到的病毒制剂范围是否反映了病毒病因或病毒检测方法的潜在变化尚不清楚,但发现的更广泛的病毒病原体突出了聚合酶链反应检测在探索儿童心肌炎可能的病毒病因方面的作用。